Overview Fundamentals API Earnings EOD API Sample Code Pricing

Gemina Laboratories Ltd (GLABF PINK) stock market data APIs

$0.33 0.02(6.4%) as of July 25, 2024
Price chart is built with Anychart

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It is developing respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.

Gemina Laboratories Ltd Financial Data Overview

0.3138
0.33
-
0.33
0.3138
0.2376-0.508
24 665 K
73 508 K
-5 443
-0.0083
0.223
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'GLABF',
Type: 'Common Stock',
Name: 'Gemina Laboratories Ltd',
Exchange: 'OTCQB',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG014RL48X6',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'January',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Gemina Laboratories Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue -5 443
  • EBITDA -5 175 819
  • Earnings Per Share -0.04
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Gemina Laboratories Ltd Earnings via APIs

  • Latest Release 2024-04-30
  • EPS/Forecast NaN

Get Gemina Laboratories Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com